Ignite Creation Date:
2025-12-25 @ 3:21 AM
Ignite Modification Date:
2026-03-11 @ 6:06 PM
Study NCT ID:
NCT02446405
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-02-06
First Post:
2015-05-04
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer
Sponsor:
Organization: